Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 15, 2020 19:47 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Announces Pricing of Public Offering of Common Stock

SEATTLE, July 15, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
July 14, 2020 16:44 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock

SEATTLE, July 14, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
July 09, 2020 08:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 10, 2020

SEATTLE, July 09, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
June 08, 2020 16:03 ET | Source: Adaptive Biotechnologies

UPDATE – Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

SEATTLE, June 08, 2020 (GLOBE NEWSWIRE) -- This release was previously disseminated on May 27, 2020 at 16:03 ET. The date and time details for the conferences have been updated. The complete and...
May 27, 2020 16:03 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

SEATTLE, May 27, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
May 12, 2020 16:03 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Reports First Quarter 2020 Financial Results

SEATTLE, May 12, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
May 06, 2020 08:00 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Present at the BofA Securities 2020 Healthcare Conference

SEATTLE, May 06, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
April 27, 2020 16:03 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report First Quarter Financial Results on May 12, 2020

SEATTLE, April 27, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
April 09, 2020 19:45 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Expands Executive Leadership Team to Support Development and Commercialization of Clinical Products, including immunoSEQ Dx

SEATTLE, April 09, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into...
February 26, 2020 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2019 Financial Results

SEATTLE, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...